Atea Pharmaceuticals Inc
NASDAQ:AVIR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Atea Pharmaceuticals Inc
NASDAQ:AVIR
|
US |
|
Far Eastern International Bank
TWSE:2845
|
TW |
|
Deceuninck NV
XBRU:DECB
|
BE |
|
Naked Wines PLC
LSE:WINE
|
UK |
|
A
|
Avalon Globocare Corp
NASDAQ:ALBT
|
US |
Wall Street
Price Targets
AVIR Price Targets Summary
Atea Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
AVIR
is 8.16 USD
with a low forecast of 6.06 USD and a high forecast of 10.5 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AVIR's stock price target?
Price Target
8.16
USD
According to Wall Street analysts, the average 1-year price target for
AVIR
is 8.16 USD
with a low forecast of 6.06 USD and a high forecast of 10.5 USD.